Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by TAKASHI TANAKA
Phase 1 Clinical Trial of a New Antiarrhythmic Drug ME3202.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
Clinic Phase I Study of a New ClassI Antiarrhythmic Drug, Moracizine(En-313).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
New Antiarrhythmic Drug for the Treatment of Atrial Fibrillation. Study Data, Clinical Guidelines, Regulatory Agency Recommendations
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
A Review On: Phase ‘0’ Clinical Trials or Exploratory Investigational New Drug
Turkish Journal of Pharmaceutical Sciences
Molecular Medicine
Pharmaceutical Science
Therapeutic Drug Monitoring: Antiarrhythmic Drugs
British Journal of Clinical Pharmacology
Pharmacology
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy in the Vanish Trial
Canadian Journal of Cardiology
Cardiovascular Medicine
Cardiology
Pneumonitis and Pulmonary Fibrosis Associated With Amiodarone Treatment: A Possible Complication of a New Antiarrhythmic Drug
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Antiarrhythmic Drug Therapy for Atrial Fibrillation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Propafenone: A Promising New Antiarrhythmic Agent
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Approaches to Phase 1 Clinical Trial Design Focused on Safety, Efficiency, and Selected Patient Populations: A Report From the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
Clinical Cancer Research
Cancer Research
Oncology
